2B70:XETRA iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)

EUR 5.96 0.02 0.404585
Icon

iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) (2B70:XETRA) Stock Analysis and Price Targets

ETF | Others | XETRA
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Very Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

EUR 5.96

+0.02 (+0.40)%

EUR 0.49B

0.22M

N/A

N/A

Icon

2B70:XETRA

iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) (EUR)
ETF | XETRA
EUR 5.96
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Very Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

EUR 0.49B

N/A

EUR 5.96

iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) (2B70:XETRA) Stock Forecast

N/A

Based on the iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) stock forecast from 0 analysts, the average analyst target price for iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) is not available over the next 12 months. iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) is Very Bearish, which is based on 0 positive signals and 1 negative signals. At the last closing, iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)’s stock price was EUR 5.96. iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)’s stock price has changed by +1.03% over the past week, -1.91% over the past month and +10.83% over the last year.

No recent analyst target price found for iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
No recent average analyst rating found for iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)

Company Overview iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)

The investment objective of the Fund is to seek to provide investors with a total return, taking into account both capital and income returns, which reflects the return of the NASDAQ Biotechnology Index.

http://www.blackrock.com

N/A

N/A

N/A

EUR

Germany

N/A

N/A

N/A

0.35 %

Adjusted Closing Price for iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) (2B70:XETRA)

Loading...

Unadjusted Closing Price for iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) (2B70:XETRA)

Loading...

Share Trading Volume for iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) Shares

Loading...

Compare Performance of iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for 2B70:XETRA

Top Sectors

N/A

Top Regions

N/A

Valuation Growth & Performance

  • 3

  • Morningstar Gbl Biotechnolo...

  • 3

  • 16.91

  • 1.69

  • -0.04

  • -1.16%

  • -0.58%

  • 5.21%

  • 0%

Stocks Similar To iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) (Sector: Others )

Symbol Name Mer Price(Change) Market Cap
XM1D:XETRA
Xtrackers MSCI Japan UCITS ETF.. 0.00 % +0.01 (+0.03%) EUR441.43B

ETFs Containing 2B70

Symbol Name 2B70's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) (2B70:XETRA) Stock

Stock Target Advisor's fundamental analysis for iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)'s stock is Very Bearish.

2B70:XETRA stock's dividend yield is 0.87%. Our analysis grades 2B70:XETRA stock's dividend yield at F. This means that 2B70:XETRA stock's dividend yield is above 6% of the stocks in the Others sector in the XETRA exchange. Based on this 2B70:XETRA may be a poor dividend stock for its sector.

Unfortunately we do not have enough data on 2B70:XETRA's stock to indicate what its average analyst target is.

Unfortunately we do not have enough data on 2B70:XETRA's stock to indicate if its overvalued.

The last closing price of 2B70:XETRA's stock was EUR 5.96.

The most recent market capitalization for 2B70:XETRA is EUR 0.49B.

Unfortunately we do not have enough analyst data on 2B70:XETRA's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)'s stock.

Sorry, we do not have any data on the number of employees for iShares Nasdaq US Biotechnology UCITS ETF USD (Acc).

Sorry we do not have any infomation available on iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)'s address.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...